Julie Ziegler

Metro Health CRSCleveland, Ohio - 44109 MetroHealth CRSCleveland, Ohio - 44109 (216-778-7847) |
- CLINICAL TRIALS 5
- CONDITIONS6
- INTERVENTIONS13
- SINCE2008

Comparative Study of Three NNRTI-Sparing HAART Regimens
May 2009 - March 2013

Optimizing Treatment for Treatment-Experienced HIV-infected People
January 2008 - August 2011

Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults
December 2009 - March 2012

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance
March 2009 - March 2013

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women
April 2008 - November 2011
Acquired Immunodeficiency Syndrome
HIV Infections
Hepatitis
Hepatitis C
Insulin Resistance
Sexually Transmitted Diseases
Maraviroc
Pioglitazone
Darunavir
Ritonavir
Raltegravir
Ribavirin
Quadrivalent Human Papillomavirus Vaccine
Emtricitabine/Tenofovir Disoproxil Fumarate
Atazanavir
Enfuvirtide
Tipranavir
Etravirine
Peginterferon



